Spark Therapeutics, Inc.

CIK 1609351 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Spark Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2020SC 13G/A0001104659-20-021673
Dec 27, 201915-12B0000950103-19-017784
Dec 18, 201930000950103-19-017350
Dec 17, 20198-K0001193125-19-315712
Dec 17, 201925-NSE0001354457-19-000652
Dec 17, 201940000899243-19-029428
Dec 17, 201940000899243-19-029435
Dec 17, 2019S-8 POS0001193125-19-316246
Dec 17, 2019S-8 POS0001193125-19-316242
Dec 17, 201940000899243-19-029444
Dec 17, 201940000899243-19-029434
Dec 17, 2019SC TO-T/A0000950103-19-017254
Dec 17, 201940000899243-19-029413
Dec 17, 201940000899243-19-029449
Dec 17, 2019S-8 POS0001193125-19-316268
Dec 17, 201940000899243-19-029433
Dec 17, 2019SC 14D9/A0001193125-19-315693
Dec 17, 2019S-8 POS0001193125-19-316253
Dec 17, 201940000899243-19-029446
Dec 17, 201940000899243-19-029452
Dec 17, 201940000899243-19-029438
Dec 17, 201940000899243-19-029440
Dec 17, 201940000899243-19-029453
Dec 17, 2019S-8 POS0001193125-19-316252
Dec 17, 2019SC 14D9/A0001193125-19-315459